Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm’s products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Analyst recommendations
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm’s products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Illumina (NASDAQ:ILMN – Get Free Report) had its price target dropped by Morgan Stanley from $136.00 to $100.00 in a research report issued on Monday,Benzinga reports. The firm currently has ...
Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price dropped 5.4% on Friday after JPMorgan Chase & Co. lowered their price target on the stock from $120.00 to $85.00. JPMorgan Chase ...
Illumina (NASDAQ:ILMN – Free Report) had its target price trimmed by Canaccord Genuity Group from $92.00 to $87.00 in a report issued on Monday morning,Benzinga reports. The brokerage currently ...
Illumina, Inc. (NASDAQ:ILMN – Get Free Report) saw some unusual options trading activity on Monday. Stock traders purchased 7,176 call options on the company. This represents an increase of ...
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes...